Correlation between trough levels of infliximab and postoperative endoscopic recurrence in Crohn’s disease patients submitted to ileocolonic resections

Postoperative Approach for Crohn's Disease: The Right Therapy to the Right Patient

(2018) Paulo Gustavo Kotze et al.   CURRENT DRUG TARGETS

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

(2018) Geert D’Haens et al.   GASTROENTEROLOGY

Systematic review and network meta-analysis Medical therapies to prevent recurrence of post-operative Crohn’s disease

(2018) Nicholas E Burr et al.   Journal of Crohns & Colitis

The Association Between Drug Levels and Endoscopic Recurrence in Postoperative Patients with Crohnʼs Disease Treated with Tumor Necrosis Factor Inhibitors

(2017) Shmuel Fay et al.   INFLAMMATORY BOWEL DISEASES

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

(2016) Miguel Regueiro et al.   GASTROENTEROLOGY

Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn’s disease: systematic reviews and economic modelling

(2016) Karoline Freeman et al.   HEALTH TECHNOLOGY ASSESSMENT

Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease

(2016) Clare Moore et al.   Journal of Crohns & Colitis

Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

(2015) Niels Vande Casteele et al.   GASTROENTEROLOGY

Direct Retrospective Comparison of Adalimumab and Infliximab in Preventing Early Postoperative Endoscopic Recurrence After Ileocaecal Resection for Crohn’s Disease: Results from the MULTIPER Database

(2015) Paulo Gustavo Kotze et al.   Journal of Crohns & Colitis

Crohn's disease management after intestinal resection: a randomised trial

(2015) Peter De Cruz et al.   LANCET

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study

(2013) Alessandro Armuzzi et al.   Journal of Crohns & Colitis

Doubling the infliximab dose versus halving the infusion intervals in Crohnʼs disease patients with loss of response

(2012) Lior Katz et al.   INFLAMMATORY BOWEL DISEASES

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE